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Abstract. Diabetic retinopathy (DR) and diabetic macular edema are common
complications of diabetes which can lead to vision loss. The grading of DR is a
fairly complex process that requires the detection of fine features such as microa-
neurysms, intraretinal hemorrhages, and intraretinal microvascular abnormalities.
Because of this, there can be a fair amount of grader variability. There are differ-
ent methods of obtaining the reference standard and resolving disagreements be-
tween graders, and while it is usually accepted that adjudication until full consen-
sus will yield the best reference standard, the difference between various methods
of resolving disagreements has not been examined extensively. In this study, we
examine the variability in different methods of grading, definitions of reference
standards, and their effects on building deep learning models for the detection of
diabetic eye disease. We find that a small set of adjudicated DR grades allows
substantial improvements in algorithm performance. The resulting algorithm’s
performance was on par with that of individual U.S. board-certified ophthalmol-
ogists and retinal specialists.
1 Introduction
Diabetic retinopathy (DR) and diabetic macular edema (DME) are among the leading
causes of vision loss worldwide. Several methods for assessing the severity of diabetic
eye disease have been established, including the Early Treatment Diabetic Retinopathy
Study Grading System [1], the Scottish Diabetic Retinopathy Grading System [2], and
the International Clinical Diabetic Retinopathy (ICDR) disease severity scale [3]. The
ICDR scale is one of the more commonly used clinical scales and consists of a 5-point
grade for DR: no, mild, moderate, severe, and proliferative.
The grading of DR is a fairly complex process that requires the identification and
quantification of fine features such as microaneurysms (MAs), intraretinal hemorrhages,
intraretinal microvascular abnormalities, and neovascularization. As a result, there can
be a fair amount of grader variability, with intergrader kappa scores ranging from 0.40
to 0.65 [1, 4–7]. This is not surprising because grader variability is a well-known issue
with human interpretation of imaging in other medical fields such as radiology [8] or
pathology [9].
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Several methods have been proposed for resolving disagreements between graders
and obtaining a reference standard. One approach consists of taking the majority deci-
sion from a group of 3 or more independent graders. Another consists of having a group
of 2 or more graders work independently and then having a third generally more senior
grader arbitrate disagreements, with that individual’s decision serving as the reference
standard. Last, a group of 3 or more graders may first grade independently and then
collectively discuss disagreements until there is full consensus on the final grade. The
difference between various methods of resolving disagreements has not been examined
extensively.
Deep learning [10] is a family of machine learning techniques that allows computers
to learn the most predictive features directly from images, given a large dataset of la-
beled examples, without specifying rules or features explicitly. It has also been applied
recently in medical imaging, producing highly accurate algorithms for a variety of clas-
sification tasks, including melanoma [11], breast cancer lymph node metastasis [12,13],
and DR [14–16] Because the network is trained to predict labels that have been paired
with the images, it is imperative that the labels accurately represent the state of disease
found in the image, especially for the evaluation sets.
In this study, we examine the variability in different methods of grading, defini-
tions of reference standards, and their effects on building deep learning models for the
detection of diabetic eye disease.
2 Methods
2.1 Development Dataset
In this work, we built upon the datasets used by Gulshan et al. [14] for algorithm de-
velopment and clinical validation. A summary of the various data sets and grading pro-
tocols used for this study is shown in Figure S1. The development dataset used con-
sists of images obtained from patients who presented for DR screening at EyePACS-
affiliated clinics, 3 eye hospitals in India (Aravind Eye Hospital, Sankara Nethralaya,
and Narayana Nethralaya), and the publicly available Messidor-2 dataset [17, 18]1. Im-
ages from the EyePACS clinics consisted of 45° retinal fundus images that were primary
(or posterior pole-centered), nasal (disc-centered), and temporal field of view. The rest
of the data sources only had primary field of view images. The images were captured us-
ing the Centervue DRS, Optovue iCam, Canon CR1/DGi/CR2, and Topcon NW using
45° fields of view. All images were de-identified according to Health Insurance Porta-
bility and Accountability Act Safe Harbor before transfer to study investigators. Ethics
review and institutional review board exemption was obtained using Quorum Review
Institutional Review Board.
There were 3 types of grades used in the development dataset: grading by EyePACS
graders, grading by ophthalmologists, and adjudicated consensus grading by retinal spe-
cialists. Images were provided at full resolution for manual grading. The images pro-
vided by EyePACS clinics were graded according to the EyePACS protocol [19]. In the
1 We have released our adjudicated grades on the Messidor-2 dataset at https://www.
kaggle.com/google-brain/messidor2-dr-grades.
2
EyePACS protocol, all 3 images of an eye (primary, nasal, and temporal) were graded
together and assigned a single grade. We assigned the grade provided for the entire eye
as a grade for each image. Although the eye-level grade may not correspond exactly
with the image-level grade, this method allowed for training on different fields of view,
which helps the algorithm tolerate some deviation from the primary field of view. The
second source of grades was the development dataset used by Gulshan et al. [14], where
each image was independently graded by ophthalmologists or trainees in their last year
of residency. The third type of grades was obtained using our subspecialist grading and
adjudication protocol on a small subset of images. Our subspecialist adjudication proto-
col consisted of 3 fellowship-trained retina specialists undertaking independent grading
of the dataset. Next, each of the 3 retina specialists reviewed the images with any level
of disagreement in a combination of asynchronous and live adjudication sessions.
For algorithm development, the development dataset was divided into groups: a
“train” set and a “tune” set. The “train” set consisted of all the images that were not
adjudicated and was used to train the model parameters. The “tune” set consisted of
images with adjudicated consensus grades and was used to tune the algorithm hyperpa-
rameters (e.g., input image resolution, learning rate) and make other modeling choices
(e.g., network architectures). All of the images in the “tune” set were of the primary
field.
2.2 Clinical Validation Dataset
The clinical validation dataset consisted of primary field of view images that were ac-
quired from EyePACS clinics (imaged between May and October 2015). These did not
overlap with any images or patients used in the development dataset.
The clinical validation set was graded using the same adjudication protocol as the
tuning set (face-to-face adjudication by 3 retina specialists). In addition, the clinical
validation set was graded by 3 ophthalmologists. These ophthalmologists were distinct
from the retina specialists who adjudicated the set. After grading, all disagreements
between the adjudicated consensus of retinal specialists and majority decision of the
ophthalmologists were reviewed manually by a retinal specialist, who also assigned a
likely reason for the discrepancy.
2.3 Algorithm Training
Our deep learning algorithm for predicting DR and DME was built upon the archi-
tecture used by Gulshan et al. [14]. We used a convolutional neural network [20] that
predicted a 5-point DR grade, referable DME, and gradability of image. The input to
the neural network was an image of a fundus, and through the use of many stages of
computation, parameterized by millions of numbers, the network output a real-valued
number between 0 and 1 for each prediction, indicating its confidence.
The parameters of a neural network were determined by training it on a dataset of
fundus images. Repeatedly, the model was given an image with a known severity rating
for DR, and the model predicted its confidence in each severity level of DR, slowly
adjusting its parameters over the course of the training process to become more accu-
rate. The model was trained via distributed stochastic gradient descent and evaluated
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on a tuning dataset throughout the training process. The tuning dataset was used to
determine model hyperparameters (parameters of the model architecture that cannot be
trained with gradient descent). Finally, we created an “ensemble” of models, training 10
individual models and combining their predictions, which improves performance and
robustness.
2.4 Algorithmic Improvements
We made a number of improvements to the core neural network, compared with the
study by Gulshan et al. [14] First, we trained our model on a larger set of images ob-
tained from EyePACS [21]. Because it would be prohibitively expensive to relabel all
of these images with U.S.-licensed ophthalmologists (as done by Gulshan et al. [14],
we also use labels determined by the EyePACS grading centers to train our DR clas-
sifier. To use both our ophthalmologist grading and the EyePACS grading effectively,
we treated the labels from these 2 independent sources as separate prediction targets,
training our model to predict both an EyePACS grade for DR and a grade determined
by our own labeling procedure, if present.
By using this larger training set, we performed a more extensive search for well-
performing hyperparameters using a Gaussian process bandit algorithm [22] One sig-
nificant change in model hyperparameters that resulted was an increase in the resolution
of images the model used as input: The model used in this work has an input resolu-
tion of 779 x 779 pixels, a large increase over the 299 x 299 pixels used by Gulshan
et al. [14]. This has the effect of increasing the effective resolution of lesions. For ex-
ample, an MA or small hard exudate may occupy only 1 pixel or less within a 299 x
299 pixel image [23, 24], but at this higher resolution, it would occupy approximately
6.8 pixels. The effective resolution of other lesions is similarly increased when using
higher input resolution.
Other significant changes included changing model architecture from “Inception-
v3” [25] to “Inception-v4” [26] and predicting a 5-class rating for DR (Gulshan et
al. [14] only predicted binary referables). For other hyperparameter and training details,
see Appendix Section A.
2.5 Evaluation
One advantage of using machine learning-based systems for predicting DR is that they
explicitly output a confidence in the range (0e1) for each image. By applying a threshold
to this confidence to determine referability, an algorithm’s sensitivity and specificity can
be tuned for a particular use case; as the threshold is lowered, the algorithm becomes
more sensitive, but less specific. Performance across many different thresholds is de-
picted in a receiver operating curve and is summarized with the area under the curve
(AUC). We used as our primary model evaluation metric for DR the AUC at differ-
ent DR severity thresholds, for example, the AUC for predicting moderate and above
DR. In addition, for some experiments on 5-class prediction we evaluated using the
quadratic-weighted Cohen’s kappa [27].
The algorithm’s sensitivity and specificity when predicting a 5-class output cannot
be tuned with a single threshold, though. Therefore, we used a cascade of thresholds,
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building on the model’s predicted confidence in each of the severity levels for DR. First,
a threshold was picked for proliferative DR: If the model’s predicted probability of an
image corresponding to proliferative DR was above a specified threshold, chosen to
reach a target sensitivity on the tuning set, the image was classified as proliferative DR.
Next, another threshold was picked for the model’s predicted probability of severe DR
and applied to all images not classified as proliferative DR. A similar procedure was ap-
plied for both moderate and mild DR. Finally, all remaining images whose probabilities
did not pass any of the thresholds were classified as no DR.
3 Results
3.1 Grading and Adjudication
The baseline characteristics of the development and clinical validation datasets are de-
scribed in Table 1. The training portion of the development set consisted of more than
1.6 M fundus images from 238 610 unique individuals. The tune portion of the develop-
ment set consisted of adjudicated consensus grades for 3737 images from 2643 unique
individuals. The clinical validation set consisted of 1958 photos from 998 unique indi-
viduals. Compared with the clinical validation set, the development set had a slightly
higher proportion of abnormal images.
A comparison of the grades generated by the majority decision from independent
grading by the retinal specialists in the panel before the adjudication process versus
the adjudicated reference standard is outlined in Table 2. Most grades remained within
1 step of each level of severity. For DR, there were 27 instances (1.5% of images)
where the difference was 2 steps, and none that were 3 or more. Adjudication more
often yielded new grades with higher levels of severity. The weighted-kappa score for
the grade determined by the majority decision of retinal specialists and by adjudication
was 0.91 (Table 3).
To better characterize the difference in each retinal specialist’s preadjudication grade
and the adjudicated consensus for detecting moderate and above DR, we measured
the sensitivity and specificity of each specialist (Table 3). Although all 3 specialists
were very specific ( 99%), sensitivity ranged from 74.4% to 82.1%, corresponding to
weighted-kappa scores of 0.82 to 0.91. A calculation of the nonadjudicated majority de-
cision of the panel of 3 retina specialists showed higher sensitivity (88.1%) than grades
from individual specialists (Table 3), leaving 11.9% of further cases with moderate or
above DR that required the adjudication process to detect. During independent grading,
some retinal specialists used a different variation for grading referable DME in which
they considered any hard exudate within the macular OCT box ( 2 disc diameters) as
referable. This discrepancy was resolved during adjudication, and all images where
referable DME was potentially present were reassessed to match the standard protocol
(where hard exudates within 1 disc diameter was considered referable DME). For this
reason, the independent grading of the retinal specialists for DME was not included in
subsequent analyses.
In addition to having retinal specialists grade and adjudicate the clinical validation
datasets, we also had 3 U.S. board-certified ophthalmologists grade the same set (Ta-
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ble 4). Quadratic-weighted kappa values were generally good (0.80 - 0.84), but some-
what lower for ophthalmologists than for the retina specialists (Table 5). The majority
decision of the ophthalmologists yielded a higher agreement (weighted kappa: 0.87)
than individual ophthalmologists alone. A comparison of all graders (3 retinal special-
ists and 3 ophthalmologists) showed that disagreements were more common in cases
in which the adjudicated consensus yielded referable disease (Figure 1). An analysis
combining the 3 retinal specialists and 3 ophthalmologists is given in Table S1.
A summary of the causes of errors in the nonadjudicated grades generated from the
majority decision of the ophthalmologists is presented in Table 6. The most common
causes were missed MAs (36%), artifacts (20%), and disagreement regarding whether
a lesion was an MA or a hemorrhage (16%). Thirty-six of 193 disagreements differed
by at least 2 grades (e.g., no DR vs. moderate or moderate vs. proliferative). Of these,
overgrading, cases in which the majority decision of the ophthalmologists was more
severe than the final adjudicated consensus grade, accounted for 14 (7.3%) of the dis-
agreements, and undergrading accounted for 22 (11.4%) of the cases.
3.2 Model Results
We compare the results of our model with the model used by Gulshan et al. [14] in Ta-
ble 7, using the majority decision or adjudicated consensus of retinal specialist grades.
For moderate or worse DR, we observed an improvement in AUC with increasing image
resolution as well as with the other algorithmic improvements outlined in the “Methods”
section for both methods of computing reference standard. However, this improvement
in AUC was larger when using the adjudicated consensus as the reference standard
(from 0.942 to 0.986 AUC). When predicting mild or worse DR (Fig 2), increasing
image resolution showed only a slight gain (¡1%) when using majority decision as
the reference standard, while when evaluating with adjudicated consensus grades we
observed that increasing resolution improved the model’s AUC from 0.952 to 0.984.
However, increasing resolution beyond approximately 450 x 450 pixel input seemed
to have marginal performance gains. Another benefit of evaluating with adjudicated
consensus grades was in reduced metric variability, where we observed reduced metric
variance (confidence intervals) across input resolutions. This was particularly impor-
tant when making changes to the algorithm because it made it easier to determine with
confidence if a change in the algorithm was actually an improvement.
We illustrate the performance of our final model using the adjudicated consensus
as the reference standard in Table 8. On 5-class DR prediction, our model achieved a
quadratic-weighted kappa of 0.84, which is on par with the performance of individual
ophthalmologists and individual retinal specialists. There were 257 disagreements be-
tween the adjudicated consensus and the model. Of the 56 (21.8%) disagreements that
were 2 or more steps, 53 (20.6%) were the result of overgrading, that is, the model
predicted a higher grade than the adjudicated consensus, and 3 (1.2%) resulted from
undergrading.
In addition to 5-point grading analysis for DR, we also demonstrate the model’s per-
formance in binary classification tasks. Figure 3 summarizes the model’s performance
as well as that of the ophthalmologists and retinal specialists in detecting mild or worse
DR, moderate or worse DR, severe or worse DR, and proliferative DR. For all of these
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classification tasks, the algorithm’s performance was approximately on par with that of
individual ophthalmologists and retinal specialists. For mild or worse DR, the algorithm
had a sensitivity of 0.970, specificity of 0.917, and AUC of 0.986.
4 Discussion
Deep learning has garnered attention recently because of its ability to create highly
accurate algorithms from large datasets of labeled data without feature engineering.
However, great care must be taken to evaluate these algorithms against as high-quality
“ground truth” labels as possible. Previous work [14] used majority decision to generate
ground truth, without an adjudication process. The present work suggests that an adju-
dication process yielding a consensus grade from multiple retina specialists provides a
more rigorous reference standard for algorithm development, especially for the iden-
tification of artifacts and missed MAs, ultimately leading to superior algorithms and
improved detection of disease.
The adjudication sessions of the 3 retina specialists yielded considerable insights
into the grading process. First, image artifacts, especially those resembling typical
pathology such as MAs, were a common source of disagreement. These disagreements
were consistent across many images, because artifacts are often caused by consistent
lens artifacts or dust spots. The adjudication process was critical in correcting these
errors. Likewise, when true pathology was present, a frequent cause of grader disagree-
ment was in differentiating an MA from an intraretinal hemorrhage, which in the ab-
sence of other findings, represented the difference between labeling an image as mild
or moderate DR. In addition, there was significant subjective variance in the precise
definition of the boundaries between grades at the outset of the adjudication process.
Although traditional grading definitions are fixed, it became very clear that there are
gray areas where these definitions are not sufficient to make an unambiguous call on
DR severity, for example, on whether a macula-centered image with numerous hemor-
rhages was more likely to represent moderate or severe DR. Once all 3 retina specialists
converged on a more precise set of definitions, staying within but also refining the tradi-
tional definitions, many of these initial disagreements were resolved. On conclusion of
the adjudication process, each of the retina specialists indicated that the precision used
in the adjudication process was above that typically used in everyday clinical practice.
A comparison of the performance of algorithm and manual grading also yielded
interesting insights. First, although manual grading by ophthalmologists led to an ap-
proximately even ratio of overgrading (7.3%) and undergrading (11.4%), the grading
by the algorithm had a higher ratio of overgrading (20.36%) than undergrading (1.2%).
This can be attributed to the decision to operate the algorithm at a very high-sensitivity
set point, which would be desirable for a screening algorithm to maximize the detection
of referable DR. However, a combination of the algorithm for initial screening coupled
with manual review of the resulting positive images would likely yield a system that is
both highly sensitive and specific, which may help limit the number of diabetic patients
being referred who do not actually have referable disease.
It is also worth noting that although full-resolution images were used for grading
and adjudication, training models using an input resolution greater than 450 x 450 pixels
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did not yield a significant boost in model performance. This suggests neural networks
may not require as high of a resolution input image to detect DR lesions as humans do.
However, this is an observation made in the setting of a specific grading scale (ICDR)
using only single nonstereoscopic 45° color fundus photographs. This observation may
not generalize if other finer grading scales are used, such as Early Treatment Diabetic
Retinopathy Study, if the input images are different (stereoscopic, ultrawide-field), or
if the ground truth incorporated signals from other clinical data, such as other types of
retinal imaging like OCT or fluorescein angiography.
There are several limitations to this study that may represent further avenues for
research. One key limitation is that we used hard exudates as a proxy for DME, which
generally requires stereoscopic images or OCT to properly diagnose and characterize.
Including OCT imaging in the process of determining ground truth for DME will be
valuable in future studies.
In addition, we used only 3 retinal specialists to establish ground truth and 3 U.S.
Board-Certified ophthalmologists as a comparison group. However, the kappa scores,
sensitivity, and specificity of the graders in this study are in line with, if not slightly bet-
ter than, what has been reported in other studies [6,7,28,29] but we found a wider range
for sensitivity, especially when it comes to detecting mild disease. For example, using
adjudication as the ground truth, the 3 retinal specialists in Abra`moff et al. [29] had
preadjudication sensitivities of 71% to 91% and specificities of 95% to 100% for call-
ing referable DR (defined as moderate or worse DR or referable DME). Likewise, our
retinal specialists had preadjudication sensitivities of 74% to 82% and specificities of
more than 99% for moderate or worse DR. Gangaputra et al. [6] reported sensitivities of
53% and 84% and specificities of 97% and 96% for clinical grading versus reading cen-
ter grading for detecting mild or worse DR. The retinal specialists and ophthalmologists
in our study had sensitivities between 70% and 80% and specificities more than 97%.
Examining the differences between adjudication and reading center grading or between
different adjudication groups would be valuable next steps in investigating variability
in grading. We also did not study the variability in grading for optometrists or other
graders trained to evaluate DR images, which is another area for further exploration.
Other areas of future work include measuring the impact of using adjudicated con-
sensus grades in the training portion of the development dataset on model performance
and studying the algorithm’s performance on other clinical validation datasets. Al-
though images in the development and clinical validation datasets of our study were
taken in nonoverlapping time intervals from the EyePACS population, additional valida-
tion on more diverse datasets in terms of cameras, geographies, and patient population
would further characterize the algorithm’s generalizability.
Despite these limitations, we believe this work provide a basis for further research
and begins to lay the groundwork for standards in this field. For example, although ad-
judication yields a more reliable ground truth, it requires significant time and resources
to perform. We demonstrate that by using existing grades and adjudicating a small sub-
set (0.22%) of the training image grades for the “tune” set, we were able to significantly
improve model performance without adjudicating the entire training corpus of images.
Leveraging these techniques, our resulting model’s performance was approximately on
par with that of individual ophthalmologists and retinal specialists.
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In conclusion, we believe that proper determination of ground truth is a critical
aspect of the development of clinically useful machine learning algorithms for use in
detection of or screening for retinal disease. We have shown that our process of live
adjudication by multiple subspecialists yielding a consensus grade provides improved
algorithmic accuracy and led to improved screening models.
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A Model Hyperparameters
For our implementation of Gulshan et al. [14], we used the following hyperparameters:
– Inception-v3 architecture. This is very slightly different from Gulshan et al., who
used an architecture just pre-dating Inception-v3.
– Input image resolution: 299× 299
– Learning rate: 0.001
– Batch size: 32
– Weight decay: 4 · 10−5
– An Adam optimizer with β1 = 0.9, β2 = 0.999, and  = 0.1. This is a difference
from Gulshan et al., who used RMSProp.
– Data augmentation:
• Random horizontal reflections
• Random brightness changes (with a max delta of 0.125) [see the TensorFlow
function tf.image.random_brightness]
• Random saturation changes between 0.5 and 1.5 [see tf.image.random_saturation]
• Random hue changes between -0.2 and 0.2 [see tf.image.random_hue]
• Random contrast changes between 0.5 and 1.5 [see tf.image.random_constrast]
• The above is done in that order. Note that Gulshan et al. applied the random
brightness, saturation, hue, and contrast changes in a random order.
– Early stopping based on tuning set DR Moderate AUC, which happened within the
first 60,000 steps.
– Model evaluations performed using a running average of parameters, with a decay
factor of 0.9999.
In our full model we used the following hyperparameters:
– Inception-v4 architecture
– Input image resolution: 779× 779
– Learning rate: 0.0014339
– Batch size: 24
– Weight decay: 1.15 · 10−5
– An Adam optimizer with β1 = 0.9, β2 = 0.999, and  = 0.1.
– Data augmentation:
• Random vertical and horizontal reflections
• Random brightness changes (with a max delta of 0.5247078)
• Random saturation changes between 0.3824261 and 1.4029386
• Random hue changes between -0.1267652 and 0.1267652
• Random contrast changes between 0.3493415 and 1.3461331
• The above is done in that order.
– Each model in a 10-way ensembled was trained for 250,000 steps.
– Model evaluations performed using a running average of parameters, with a decay
factor of 0.9999.
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Tables and Figures
Development Clinical Validation
Train Tune EyePACS-2
Images (#) 1,665,151 3,737 1,958
Patient Demographics
Unique Individuals (#) 238,610 2,643 999
Age (Average ± Stdev) 53.5 ± 11.6 54.3 ± 11.1 54.9 ± 10.9
Female / Total patients
where gender was known
140,183/230,556 (60.8%) 1,101/1,767 (62.3%) 603/999 (60.5%)
Image Quality Distribution
Fully gradable / Total images
where image quality was
assessed
1,343,726/1,529,771 (87.8%) 3,547/3,737 (94.9%) 1,813/1,958 (92.6%)
Development Validation
Train Tune EyePACS-2
Disease Severity
Distribution # % # % # %
Total images where DR
was assessed
1,662,646 100.0% 3,547 100.0% 1,813 100.0%
No diabetic retinopathy 1,164,368 70.0% 2,417 68.1% 1,478 81.5%
Mild 152,938 9.2% 458 12.9% 125 6.9%
Moderate 249,138 15.0% 497 14.0% 144 7.9%
Severe 50,640 3.0% 106 3.0% 50 2.8%
Proliferative 45,562 2.7% 69 1.9% 16 0.9%
Total images where DME
was assessed
252,544 100.0% 3,547 100.0% 1,813 100.0%
Referable diabetic macular
edema
28,807 11.4% 281 7.9% 79 4.4%
Table 1. Summary of image characteristics and available demographic information in the devel-
opment and clinical validation datasets. The adjudicated reference standard was used for comput-
ing the DR and DME distributions on the “Tune” and “EyePACS-2” datasets, and the majority
reference standard was used for the “Train” dataset. For DR, the majority was taken over both the
EyePACS partner grade, and the grading done by our ophthalmologists (using whichever grades
are available). For DME, the majority is taken over grades from our ophthalmologists. For Image
quality distributions, the EyePACS partner grade was used for the “Train” dataset and an adju-
dicated image quality standard was used for the “Tune” and “EyePACS-2” datasets. The “Tune”
dataset and “Validation” dataset differ in their definition of DME used during adjudication: the
“Tune” dataset used a standard of hard exudates within 2 disc diameter (DD) of the fovea (to
approximate the macular OCT box), whereas the “Validation” dataset used a standard of hard
exudates within 1 DD of the fovea.
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Majority decision of retinal specialist grading
before adjudication
No Mild Moderate Severe Proliferative
Adjudicated
Consensus
No 1,469 4 5 0 0
Mild 58 62 5 0 0
Moderate 22 3 118 1 0
Severe 0 0 13 36 1
Proliferative 0 0 0 1 15
Table 2. Comparison of retinal specialist grades before and after adjudication on the validation
dataset. Confusion matrix for diabetic retinopathy between the grade determined by majority
decision and adjudicated consensus.
DR
Sensitivity Specificity
Quadratic-
weighted kappa
Retina Specialist A 74.6% 99.1% 0.82
Retina Specialist B 74.4% 99.3% 0.80
Retina Specialist C 82.1% 99.3% 0.91
Majority Decision
(Retinal Specialists)
88.1% 99.4% 0.91
Table 3. Agreement between each retina specialist and the adjudicated reference standard on the
validation dataset. Retina specialists correspond to those who contributed to the final adjudicated
reference standard. Sensitivity and specificity metrics reported are for moderate or worse DR.
Agreement between the preadjudication 5-point DR grade and the final adjudicated grade is also
measured by the quadratic-weighted kappa.
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Majority of ophthalmologist grading
No Mild Moderate Severe Proliferative
Adjudicated
Consensus
No 1,432 32 10 0 1
Mild 67 38 19 1 0
Moderate 20 14 94 14 2
Severe 0 0 9 41 0
Proliferative 0 0 1 2 13
Majority of ophthalmologist
grading
Not Referable Referable DME
Adjudicated
Consensus
Not Referable 1,710 17
Referable DME 13 65
Table 4. Comparison of ophthalmologist grades versus adjudicated grades from retina specialists
on the validation dataset. Confusion matrix for diabetic retinopathy and DME between the grade
determined by majority decision of the ophthalmologists and the adjudicated consensus of retinal
specialists.
DR DME
Sensitivity Specificity
Quadratic-
weighted kappa
Sensitivity Specificity
Ophthalmologist A 75.2% 99.1% 0.84 81.5% 98.7%
Ophthalmologist B 74.9% 97.9% 0.80 62.7% 98.6%
Ophthalmologist C 76.4% 97.5% 0.82 86.4% 99.1%
Majority Decision
(Ophthalmologists)
83.8% 98.1% 0.87 83.3% 99.0%
Table 5. Agreement between ophthalmologists’ grades with the adjudicated reference standard
on the validation dataset. Sensitivity and specificity metrics are for moderate or worse DR and
referable DME for each grader. Agreement between the adjudicated grade and the 5-point scale
is also measured by the quadratic-weighted kappa.
15
Adjudication Consensus Grade (Retina Specialists) minus
Majority Decision Grade (Ophthalmologists)
-4 -2 -1 1 2 Total
Artifact vs not 5 28 1 5 39
Extent of Lesions 1 16 9 26
Hemorrhage vs MA 1 13 13 3 30
Hemorrhage vs not 4 4 11 19
IRMA vs not 1 1
Missed hemorrhage 2 2
Missed MA 6 63 69
Missed NVD/NVE 2 1 3
PRP vs not 1 1 1 3
Other 1 1
Total 1 13 65 92 22 193
Table 6. Reasons for difference between adjudication of retinal specialist and majority decision
from ophthalmologist graders. Disagreements between the adjudicated consensus and majority
decision were examined and characterized by a retinal specialist. Positive numbers denote that
the adjudication grade was more than the majority decision of ophthalmologist grade, and vice-
versa for negative numbers.
Original Model Original Model,High Resolution Our Full Model
Majority decision of
retinal specialists ground truth 0.952 0.978 0.986
Adjudicated consensus
ground truth 0.942 0.960 0.986
Table 7. Differences in the Final Area under the Curve Observed for Algorithms Trained in the
Image Resolution Algorithm Selection Experiments for Moderate or Worse Diabetic Retinopathy.
Majority decision was based on the grades of the 3 retinal specialists. “Original Model” refers
to the model and training data of Gulshan et al. [14] “Original Model, High Resolution” uses
higher resolution input images (779 x 779 pixels), and “Our Full Model” incorporates all changes
described in the “Algorithmic Improvements” section in the main text.
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Algorithm Grade
No Mild Moderate Severe Proliferative
Adjudicated
Consensus
No 1,356 74 44 1 3
Mild 7 43 74 0 1
Moderate 3 3 98 36 4
Severe 0 0 2 47 1
Proliferative 0 0 0 4 12
Algorithm Grade
Not Referable Referable DME
Adjudicated
Consensus
Not Referable 1,637 97
Referable DME 4 75
DR DME
Sensitivity Specificity
Quadratic-
weighted kappa
Sensitivity Specificity
Algorithm 97.1% 92.3% 0.84 94.9% 94.4%
Table 8. Comparison of algorithm grade versus adjudicated grades from retina specialists. Con-
fusion matrix for DR and DME where the grade is determined by the algorithm or adjudicated
consensus of the retinal specialists. Sensitivity and specificity metrics reported are for moderate
or worse DR and referable DME.
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Fig. 1. Grader agreement based on the adjudicated consensus grade for referable diabetic
retinopathy (DR) and diabetic macular edema (DME). Independent grading of all 3 retinal spe-
cialists and all 3 ophthalmologists are included in this analysis.
Fig. 2. Image resolution input to model versus area under the curve (AUC) for mild and above
DR. Left: Using majority decision of retinal specialists as the reference standard. Right: Using the
adjudicated consensus grade of retinal specialists as a reference standard. Shaded areas represent
a 95% confidence interval as measured via bootstrapping.
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Fig. 3. Comparison of the algorithm, ophthalmologists, and retinal specialists using the adjudi-
cated reference standard at various DR severity thresholds. The algorithm’s performance is the
blue curve. The 3 retina specialists are represented in shades of orange/red, and the 3 ophthal-
mologists are in shades of blue. N = 1813 fully gradable images.
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Majority of retinal specialist
and ophthalmologist grading
No Mild Moderate Severe Proliferative
Adjudicated
Consensus
No 1,472 3 3 0 0
Mild 65 55 5 0 0
Moderate 26 6 109 3 0
Severe 0 0 10 40 0
Proliferative 0 0 1 2 13
Majority of retinal specialist
and ophthalmologist grading
Not Referable Referable DME
Adjudicated
Consensus
Not Referable 1,695 2
Referable DME 23 93
Table S1. Comparison of combined retina specialist and ophthalmologist grades versus adju-
dicated grades from retina specialists. Confusion matrix for DR and DME where the grade is
determined by either the majority decision of all six retina specialists and ophthalmologists or is
the adjudicated consensus of the retinal specialists.
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Fig. S1. Diagram of the different image sources and grading protocols used for development
and clinical validation. The algorithm was trained on the development set only, which consisted
of a train set to train the model parameters and the tune set to tune the models performance
(hyperparameter tuning and picking checkpoints).
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Fig. S2. STARD diagram for DR.
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Fig. S3. STARD diagram for DME.
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